Mavoglurant developmental code name AFQ-056 is an experimental drug candidate for the treatment of fragile X syndrome. Reference standards of Mavoglurant API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
No Data Found
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
